Last updated: May 18, 2016
|CMS Measure ID:||CMS135v3|
Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge
|Initial Patient Population:||
All patients aged 18 years and older with a diagnosis of heart failure
Equals Initial Patient Population with a current or prior LVEF < 40%
Patients who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge
|Measure Steward:||American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)|
|Domain:||Effective Clinical Care|
|Next Version:||Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)|
Higher score indicates better quality
To meet this measure, it must be reported for all heart failure patients a minimum of once during the measurement period when seen in the outpatient setting AND reported at each hospital discharge during the measurement period.
The requirement of Count >=2 of Encounter, Performed is to establish that the eligible professional has an existing relationship with the patient.